Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $61.5200 (2.09%) ($60.2600 - $61.8000) on Wed. Sep. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.52% (three month average) | RSI | 40 | Latest Price | $61.5200(2.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND declines -2.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) PEJ(63%) ACES(61%) XLE(59%) XOP(53%) VT(40%) | Factors Impacting LGND price | LGND will decline at least -0.76% in a week (0% probabilities). IFRA(-12%) ICLN(0%) IDRV(59%) IWD(5%) IWN(32%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.76% (StdDev 1.52%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $54.35(-11.65%) | Resistance Level | $62.51 | 5 Day Moving Average | $59.81(2.86%) | 10 Day Moving Average | $60.94(0.95%) | 20 Day Moving Average | $62.51(-1.58%) | To recent high | -15.2% | To recent low | 4.6% | Market Cap | $989m | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |